Akebia Therapeutics, Inc.

AKBA · Healthcare · $244M

$0.91+2.67%

Price

$1.21

$1.00

Jul 1, 26Sep 30, 26

What's this stock's score right now?

See its score for free — revenue and money flow, graded on one standard.

Quarterly Financials

RevenueOperating IncomeNet Income

9/'26

Revenue$47M-5.2%

6/'26 vs prev quarter

Company Health

Market Cap$244M

Operating Margin-6.9%

Cash on Hand$156M63.7% of market cap

Free Cash Flow$41M17.0% of market cap

Among 327 Biotechnology peers

LowMedianHigh

PSR1.1xmedian 11.4xPBR9.5xmedian 2.0xROE-118.6%median -54.5%